Despite the observed associations between BRCA1 and BRCA2 germline pathogenic variant status with ovarian tumour characteristics, currently VUS interpretation efforts do not consider ovarian tumour pathology. The gene discussed is BRCA1; the disease is ovarian neoplasm.